MAPKAPK5 and hepatocellular carcinoma: Next, based on median MAPKAPK5-AS1expression in HCC tissues, patients were divided into MAPKAPK5-AS1 high or low-group to explore the clinical significance of MAPKAPK5-AS1 in HCC.